Searchable abstracts of presentations at key conferences in endocrinology

ea0073aep83 | Calcium and Bone | ECE2021

Efficacy and safety of long-term treatment with monthly calcifediol soft capsules in vitamin D deficient patients

Esteban Jódar , Perez-Castrillon Jose Luis , Antonio Dueñas , Hernandez Gonzalo , Fernandez Nieves , Sandra Pamela Chinchilla Gallo

BackgroundVitamin D has shown to play a role in multiple diseases due to its skeletal and extraskeletal actions (such as immunomodulation). In this sense, vitamin D deficiency has become a worldwide health issue. Few supplementation guidelines mention calcifediol treatment, its optimal dosing and treatment duration, despite being the direct precursor of calcitriol and the biomarker of vitamin D status.Objectives<p class="abstex...

ea0092ps3-30-06 | Thyroid Physiology in Periphery &amp; Development Basic | ETA2023

Development and characterization of a simple human thyroid organoid in vitro model for thyroid metabolism investigation

cristiani sofia , Bertolini Andrea , Carnicelli Vittoria , contu lucia , Chiellini Grazia , Ghelardoni Sandra , Rutigliano Grazia , Lenzi Paola , Bizzarri Ranieri

Please Development and preliminary characterization of a simple human thyroid organoid in vitro model for thyroid metabolism investigation For decades, in vitro studies of the thyroid have relied on thyroid-derived tumor cell lines, which are limited by their undifferentiated phenotype, lack of response to TSH, and chromosomal abnormalities. A viable alternative are monolayer (2D) cultures of primary thyrocytes isolated from histologically normal thyroid glan...

ea0093oc19 | Oral communication 3: Adrenal Tumors and Neuroendocrine Tumors | EYES2023

FGF/FGFR signaling in adrenocortical tumorigenesis: Novel potential therapeutic targets in adrenocortical carcinoma

Kappenstein Lena , Paul Alexander , Altieri Barbara , Sbiera Iuliu , Sandra Sigala , Alfredo Berruti , Fassnacht Martin , Sbiera Silviu , Tamburello Mariangela

Background: Adrenocortical carcinoma (ACC) is one of the most aggressive endocrine malignancies. The Fibroblast Growth Factor/Fibroblast Growth Factor Receptor (FGF/FGFR) pathway plays a role in both embryogenesis and tumorigenesis of adrenal gland. Our group demonstrated that FGFR1-4 were upregulated in ACCs and that their high expression was significantly associated with worse prognosis, suggesting that they are potentially interesting therapeutic targets.<p class="abste...

ea0099p48 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Screening for gestational diabetes in the first trimester: the impact of fasting blood glucose in maternal and foetal health

Carreira Ana , Lopes Sofia , Hundarova Kristina , Lobo Antonio , Ceu Almeida Maria , Ruas Luisa , Paiva Sandra , Melo Miguel , Paiva Isabel

Introduction: Screening for gestational diabetes (GD) in the first trimester using fasting plasma glucose (FPG) ≥92 mg/dl is routinely performed in several countries. However, evidence on the benefits and harms of early universal screening, as well as the optimal cut-off of FPG, is conflicting. This results in lack of standardised screening and treatment approaches for GD worldwide.Aims: o compare the use of pharmacological treatment and pregnancy ...

ea0099ep319 | Pituitary and Neuroendocrinology | ECE2024

Gender related metabolic differences in hypopituitarism

Miljic Dragana , Nikolic Djurovic Marina , Doknic Mirjana , Djurdjevic Sandra , Stojanovic Marko , Jemuovic Zvezdana , Cekic Ivana , Jevtic Ivan , Petakov Milan

Background: Hypopituitarism is characterised by multiple pituitary hormone deficiencies causing adverse metabolic milleu and body composition changes. Aim: Our aim was to investigate the gender related differences in the prevalence of metabolic syndrome (MetS) and metabolic profiles in patients with hypopituitarism compared to obese controls. Patients and methods: A retrospective study of 282 patients with hypopituitarism (136 wome...

ea0099ep1319 | Late Breaking | ECE2024

Peculiar case of post-gastrectomy noninsulinoma pancreatogenous hypoglycemic syndrome

Ilić Saša , Popovic Bojana , Gostiljac Drasko , Milic Gordana , Pekic Djurdjevic Sandra , Miljic Dragana , Ristic Masa , Dimitrijevic Sreckovic Vesna

For the diagnosis of hyperinsulinemic hypoglycemia (HH), it is necessary that in symptomatic hypoglycemia in the fasting test the insulin/glucose ratio is >0.3, or that in spontaneous hypoglycemia there are C-peptide >0.6 nmol/l and insulin >3.0 mIU/ml. It is a well-known fact about the increasing frequency of hypoglycemia after bariatric surgery (estimated up to 30% of patients), mostly within the Dumping syndrome, but the frequency of occurrence of noninsulinoma ...

ea0077p219 | Neuroendocrinology and Pituitary | SFEBES2021

Pituitary apoplexy- a retrospective analysis of clinical features, management and outcomes

Ghenoiu Sandra , Ciubotaru Gheorghe Vasile , Dumitraucu Anda , Căpăt.ină Cristina , Poiană Cătălina

Introduction: The term “pituitary apoplexy” (PA) describes the appearance of abrupt hemorrhage and/or ischaemia of the constituents of sella turcica, usually in a pre-existing pituitary tumor. The presentation of this syndrome may be acute or subclinical.Objective: This study aims to assess clinical, imaging and hormonal features and the outcomes following surgery or conservative treatment among pituitary adenoma patients presenting with PA.</p...

ea0081p60 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Performance of EKFC, FAS and 2021 CKD-EPI equations for estimating glomerular filtration rate in people with type 2 diabetes

Martins Rocha Bruna , Escott Gustavo Monteiro , Fagundes Silva Luiza Carolina , Franciele Porgere Indianara , Tochetto Luis Afonso , de Almeida Brondani Leticia , Silveiro Sandra Pinho

Background: Diabetes mellitus (DM) is the leading cause of chronic kidney disease (CKD) worldwide. In clinical practice, kidney function is routinely assessed through glomerular filtration rate (GFR) estimated by equations. However, the accuracy of current equations has been questioned for people with diabetes mellitus (DM).Aim: To evaluate the performance of the European Kidney Function Consortium (EKFC), the Full Age Spectrum (FAS) and the 2021 Chronic...

ea0081p669 | Pituitary and Neuroendocrinology | ECE2022

From silent to carcinoma: the genomic alterations landscape of whole spectrum macroadenoma corticotrope pituitary tumors and carcinoma

Taniguchi Keiko , Andonegui-Elguera Sergio , Elena Silva Roman Gloria , Pena-Martinez Eduardo , Vela Patino Sandra , Remba-Shapiro Ilan , Mercado Moises , Marrero-Rodriguez Daniel

Corticotrope cells give arise to utmost aggressive and to very rare pituitary neoplasias, including pituitary carcinomas, Crooke’s cell adenomas (CCA), clinically non-functioning silent corticotrope adenomas (SCA) and the Cushing-provoking pituitary adenomas (CD). The molecular etiopathogenesis of these tumors are still poorly understood. Therefore, we carried out whole exome sequencing to better understand the full genomic landscape single nucleotide variants and copy nu...

ea0081p464 | Thyroid | ECE2022

Steroid treatment in the management of destructive thyrotoxicosis induced by PD1 blockade

Brancatella Alessandro , Pierotti Laura , Lupi Isabella , Montanelli Lucia , Viola Nicola , Sgro Daniele , Sardella Chiara , Antonangeli Lucia , Brogioni Sandra , Cremolini Chiara , Marcocci Claudio , Santini Ferruccio , Latrofa Francesco

Objective: Destructive thyroiditis is the most common endocrine immune related adverse event (iRAEs) in patients treated with anti-PD1/PD-L1 agents. Given its self-limited course, current guidelines recommend no treatment for this iRAE. Nevertheless in patients with enlarged thyroid volume and a poor performance status, thyrotoxicosis may be particularly severe and harmful. Aim of the study is to evaluate if steroid treatment might be useful in improving thyrotoxicosis in subj...